Results 201 to 210 of about 71,405 (265)
Vacuolization as a Novel Approach to Cancer Therapy
This review discusses the novel strategy of inducing vacuole formation in cancer cells using small molecules, that induce nonapoptotic cell death mechanisms, such as paraptosis, oncosis, autophagy, and methuosis, and its potential in overcoming resistance to apoptosis‐based cancer therapies.
Mariah Pasternak +9 more
wiley +1 more source
Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report. [PDF]
Nilsen O +6 more
europepmc +1 more source
Primary hepatic cancer (PHC), especially hepatocellular carcinoma (HCC), is still a significant burden worldwide. The efficacy of diagnosis, treatment response monitoring, and prognostication using laboratory biomarkers is still a challenge. This study analyzed multi‐laboratory parameters pre‐ and post‐treatment and their associations with clinical and
Xiaowei Chi +3 more
wiley +1 more source
RETRACTED: Wen et al. PTEN Deficiency Induced by Extracellular Vesicle miRNAs from <i>Clonorchis sinensis</i> Potentiates Cholangiocarcinoma Development by Inhibiting Ferroptosis. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 10350. [PDF]
Wen L, Li M, Yin J.
europepmc +1 more source
E. faecalis is enriched in HCC tissue and can promote liver tumourigenesis by activating mTOR signalling pathway. Obg derived from E. faecalis extracellular vesicles (EVs) is a GTPase physically interacts with mTOR, and acts as an interkingdom activator of mTOR. EF‐Obg expression level in HCC tissue correlates with poor prognosis in HCC patients.
Ning Ma +18 more
wiley +1 more source

